ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Flex-a-New on Osteoarthritis of the Knee

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00294801
Recruitment Status : Unknown
Verified February 2006 by Rabin Medical Center.
Recruitment status was:  Recruiting
First Posted : February 22, 2006
Last Update Posted : February 22, 2006
Sponsor:
Information provided by:
Rabin Medical Center

Brief Summary:
comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

Condition or disease Intervention/treatment Phase
Osteoarthritis Drug: flex-a-new (food supplement) Phase 4

Detailed Description:
comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

Study Type : Interventional  (Clinical Trial)
Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Study Start Date : January 2006
Study Completion Date : December 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources




Primary Outcome Measures :
  1. KOOS

Secondary Outcome Measures :
  1. VAS KSS


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

knee osteoarthritis grade 1 to 3 -

Exclusion Criteria:

ischemic heart disease with CHF -


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00294801


Locations
Israel
Rabin Medical Center Recruiting
Petah Tikwa, Israel, 49372
Contact: dror robinson, md    972-3-9372233    drorr@clalit.org.il   
Principal Investigator: dror robinson, md         
Sponsors and Collaborators
Rabin Medical Center
Investigators
Principal Investigator: dror robinson Rabin Medical Center

ClinicalTrials.gov Identifier: NCT00294801     History of Changes
Other Study ID Numbers: flex-a-new
First Posted: February 22, 2006    Key Record Dates
Last Update Posted: February 22, 2006
Last Verified: February 2006

Keywords provided by Rabin Medical Center:
knee osteoarthritis

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases